Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population

Viral Immunology

Volumn 25, Issue 1, 2012, Pages 73-78

  Song, Qi Long ^a   He, Xing Xing ^a   Yang, Hong ^a   Li, Jin ^a   Chen, Man ^a   Wang, Meng Yi ^a   Liu, Qing ^b   Yu, Jin Ling ^a   Yao, Jin Jian ^a   Liu, Li Feng ^a   Sun, Shu Zhen ^a   Lin, Ju Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINESE; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PROTECTION; SINGLE NUCLEOTIDE POLYMORPHISM; TANK GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

HEPATITIS B VIRUS;

EID: 84863014631     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0053     Document Type: Article

References (36)

1. Guo X, Zhang Y, Li J, et al.: Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011;53:422-428.
2. Guo XC, and Wu YQ: A review: progress of prevention and control on viral hepatitis in China. Biomed Environ Sci 1999; 12:227-232.
3. Lai CL, Ratziu V, Yuen VF, and Poynard T: Viral hepatitis B. Lancet 2003;362:2089-2094. (Pubitemid 38032767)
4. Clementi M, and Di Gianantonio E: Genetic susceptibility to infectious diseases. Reprod Toxicol 2006;21:345-349.
5. Casanova JL, and Abel L: Human genetics of infectious diseases: a unified theory. EMBO J 2007;26:915-922.
6. He XX, Chang Y, Jiang HJ, et al.: Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection. Viral Immunol 2007;23:251-257.
7. Hann HW, Kim CY, London WT, et al.: Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea. Int J Cancer 1982;30:47-51. (Pubitemid 12044234)
8. Lin TM, Chen CJ, Wu MM, et al.: Hepatitis B virus markers in Chinese twins. Anticancer Res 1989;9:737-741. (Pubitemid 19194309)
9. Kaye KM, Devergne O, Harada JN, et al.: Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc Natl Acad Sci USA 1996;93:11085-11090.
10. Hohler T, Kruger A, Gerken G, et al.: A tumor necrosis factor- alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998;111:579-582. (Pubitemid 28160904)
11. Bellamy R, Ruwende C, Corrah T, et al.: Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999;179:721-724. (Pubitemid 30016163)
12. Ben-Ari Z, Mor E, Papo O, et al.: Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003;98:144-150. (Pubitemid 36135183)
13. Deng G, Zhou G, Zhai Y, et al.: Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004;40:318-326. (Pubitemid 39062849)
14. Kamatani Y, Wattanapokayakit S, Ochi H, et al.: A genomewide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009;41:591-595.
15. Albayrak A, Ertek M, Tasyaran MA, and Pirim I: Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey. Biochem Genet 2010;49:258-269.
16. Cheng G, and Baltimore D: TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. Genes Dev 1996;10:963-973.
17. Rothe M, Xiong J, Shu HB, et al.: I-TRAF is a novel TRAFinteracting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA 1996;93:8241-8246. (Pubitemid 26269541)
18. Pomerantz JL, and Baltimore D: NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 1999;18:6694-6704.
19. Nomura F, Kawai T, Nakanishi K, and Akira S: NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Genes Cells 2000;5:191-202. (Pubitemid 30227841)
20. Sun B, and Karin M: NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene 2008;27:6228-6244.
21. Oakley F, Teoh V, Ching ASG, et al.: Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 2009;136:2334-2344, e2331.
22. Guo B, and Cheng G: Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 2007;282:11817-11826. (Pubitemid 47100710)
23. EASL clinical practice guidelines. Management of chronic hepatitis B. Gastroenterol Clin Biol 2009 33 539-554.
24. Zeng Z, Guan L, An P, et al.: A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis 2008;8:1.
25. Wang SS, Purdue MP, Cerhan JR, et al.: Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non- Hodgkin lymphoma risk. PLoS One 2009;4:e5360.
26. Karin M, and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000;18:621-663. (Pubitemid 30365393)
27. Hayden MS, and Ghosh S: Signaling to NF-kappaB. Genes Dev 2004;18:2195-2224.
28. Albayrak A, Uyanik MH, Cerrah S, et al.: Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment? Viral Immunol 2010 23 633-638.
29. Bonif M, Meuwis MA, Close P, et al.: TNFalpha- and IKKbeta- mediated TANK/I-TRAF phosphorylation. Biochem J 2006;394:593-603.
30. Lin YC, Hsu EC, and Ting LP: Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB. Cell Microbiol 2009;11:645-660.
31. Luedde T, and Schwabe RF: NF-kappaB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2011;8:108-118.
32. Suneetha PV, Sarin SK, Goyal A, et al.: Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. J Hepatol 2006;44:856-863.
33. Miyazoe S, Hamasaki K, Nakata K, et al.: Influence of interleukin- 10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002;97:2086-2092.
34. Migita K, Maeda Y, Abiru S, et al.: Polymorphisms of interleukin- 1beta in Japanese patients with hepatitis B virus infection. J Hepatol 2007;46:381-386. (Pubitemid 46185698)
35. Zhang X, Deriaud E, Jiao X, et al.: Type I interferons protect neonates from acute inflammation through interleukin 10- producing B cells. J Exp Med 2007;204:1107-1118. (Pubitemid 46798154)
36. Rehermann B, Fowler P, Sidney J, et al.: The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047-1058.